3rd International Conference on Probiotics, Prebiotics & Gut Health
The 3rd International Conference on Probiotics, Prebiotics & Gut Health will be held from April 3–5, 2025, in Barcelona, Spain, bringing together leading microbiologists, gastroenterologists, nutrition scientists, biotechnologists, healthcare professionals, and industry experts. This global congress aims to provide a premier platform for sharing the latest research advancements and clinical breakthroughs in microbiome science and gut health therapeutics. Over three dynamic days, participants will engage in keynote lectures, scientific sessions, panel discussions, and poster presentations covering emerging trends in probiotics, prebiotics, synbiotics, postbiotics, microbiome-based therapies, digestive disorders, immune modulation, metabolic health, and personalized nutrition. The conference will highlight translational research bridging laboratory discoveries with clinical practice and commercial innovation. With increasing recognition of the gut microbiome’s role in overall health, the event fosters interdisciplinary collaboration among academia, clinical researchers, pharmaceutical innovators, and functional food industries. The congress serves as a strategic forum for advancing microbiome- driven healthcare solutions and developing sustainable, science-backed probiotic technologies.
Scientific Objectives
The primary scientific objective of the 3rd International Conference on Probiotics, Prebiotics & Gut Health is to advance research and clinical understanding of the human microbiome and its impact on systemic health. By gathering leading scientists and healthcare professionals, the congress aims to promote knowledge exchange on emerging probiotic strains, microbial therapeutics, and innovative gut health interventions. A key focus of the conference is to explore the role of microbiota in chronic diseases, including inflammatory bowel disease, metabolic syndrome, obesity, autoimmune conditions, and neurological disorders. Through evidence-based research presentations, the event seeks to strengthen translational pathways that convert microbiome discoveries into safe and effective therapeutic strategies. Additionally, the congress emphasizes innovation in probiotic product development, quality control, regulatory frameworks, and personalized microbiome solutions. By fostering collaboration between researchers, clinicians, and biotechnology industries, the conference aims to accelerate scientific breakthroughs that improve global digestive and immune health outcomes.
